Artwork

Content provided by Joubin Mirzadegan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Joubin Mirzadegan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

#174 CEO and Co-Founder Ginkgo Bioworks, Jason Kelly: Life Finds a Way

59:42
 
Share
 

Manage episode 396869088 series 2662695
Content provided by Joubin Mirzadegan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Joubin Mirzadegan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Guest: Jason Kelly, CEO and co-founder of Ginkgo Bioworks

Almost everyone in the second generation of biotechnology entrepreneurs, says Ginkgo Bioworks CEO Jason Kelly, works in that field because of one thing: Jurassic Park. The Michael Crichton novel-turned-Steven Spielberg movie captured both the wonder and beauty of bioengineering, and the challenges of bending DNA to your own ends. “You didn’t invent biology,” Jason says. “You need to have humility in the face of it ... because life will find a way. It will do things you don’t expect. It’s not a computer.”

In this episode, Jason and Joubin discuss the Wall Street rollercoaster, designer cells, the history of biotech, Herbert Boyer and Genentech, ChatGPT, extinct flowers, Sam Altman and YCombinator, first principles thinking, compounding risk, Patrick Collison, super-voting shares, capital intensive businesses, Pets.com, and why biology is like “freakishly powerful alien technology.”

In this episode, we cover:

  • Being private vs. being public (00:58)
  • How bioengineering works (04:27)
  • Jurassic Park (08:51)
  • Biotech breakthroughs (12:15)
  • Why this field is not well-known yet (16:57)
  • “The ChatGPT moment for biotech” (22:05)
  • Meaningful stuff takes forever (26:23)
  • Ginkgo’s first five years (29:02)
  • Why the company went public (36:20)
  • Short sellers, Warren Buffett, and Elon Musk (42:08)
  • Applying AI to DNA engineering (47:57)
  • The long-term future (55:57)
  • Who Ginkgo is hiring (58:39)

Links:

  continue reading

196 episodes

Artwork
iconShare
 
Manage episode 396869088 series 2662695
Content provided by Joubin Mirzadegan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Joubin Mirzadegan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Guest: Jason Kelly, CEO and co-founder of Ginkgo Bioworks

Almost everyone in the second generation of biotechnology entrepreneurs, says Ginkgo Bioworks CEO Jason Kelly, works in that field because of one thing: Jurassic Park. The Michael Crichton novel-turned-Steven Spielberg movie captured both the wonder and beauty of bioengineering, and the challenges of bending DNA to your own ends. “You didn’t invent biology,” Jason says. “You need to have humility in the face of it ... because life will find a way. It will do things you don’t expect. It’s not a computer.”

In this episode, Jason and Joubin discuss the Wall Street rollercoaster, designer cells, the history of biotech, Herbert Boyer and Genentech, ChatGPT, extinct flowers, Sam Altman and YCombinator, first principles thinking, compounding risk, Patrick Collison, super-voting shares, capital intensive businesses, Pets.com, and why biology is like “freakishly powerful alien technology.”

In this episode, we cover:

  • Being private vs. being public (00:58)
  • How bioengineering works (04:27)
  • Jurassic Park (08:51)
  • Biotech breakthroughs (12:15)
  • Why this field is not well-known yet (16:57)
  • “The ChatGPT moment for biotech” (22:05)
  • Meaningful stuff takes forever (26:23)
  • Ginkgo’s first five years (29:02)
  • Why the company went public (36:20)
  • Short sellers, Warren Buffett, and Elon Musk (42:08)
  • Applying AI to DNA engineering (47:57)
  • The long-term future (55:57)
  • Who Ginkgo is hiring (58:39)

Links:

  continue reading

196 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide